Effect of duration of the GnRH agonists in the luteal phase in the outcome of assisted reproduction cycles

Gynecological Endocrinology

Volumn 29, Issue 6, 2013, Pages 608-610

  Geber, Selmo ^a   Sampaio, Marcos ^a  

^a Centro de Medicina Reprodutiva   (Brazil)

Author keywords

Assisted reproduction; GnRH agonists; Luteal phase; Pregnancy rate

Indexed keywords

GOSERELIN;

ADULT; ARTICLE; DRUG EFFECT; ESTRUS CYCLE; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; MAJOR CLINICAL STUDY; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FERTILITY AGENTS, FEMALE; GONADOTROPIN-RELEASING HORMONE; GOSERELIN; HUMANS; LUTEAL PHASE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; REPRODUCTIVE TECHNIQUES, ASSISTED; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84877624384     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2013.788635     Document Type: Article

References (26)

1. Neveu S, Hedon B, Bringer J, et al. Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization. Fertil Steril 1987;47:639-43
2. Rutherford AJ, Subak-Sharpe RJ, Dawson KJ, et al. Improvement of in vitro fertilisation after treatment with buserelin, an agonist of luteinising hormone releasing hormone. Br Med J 1988;25:1765-8
3. Tummon IS, Daniel SA, Kaplan BR, et al. Randomized, prospective comparison of luteal leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins in 408 first cycles of in vitro fertilization. Fertil Steril 1992;58:563-8
4. Hughes EG, Fedorkow DM, Daya S, et al. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: A meta-Analysis of randomized controlled trials. Fertil Steril 1992;58:888-96
5. Macklon NS, Stouffer RL, Giudice LC, Fauser BCJM. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev 2006;27:170-207
6. Tan SL, Kingsland C, Campbell S, et al. The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization. Fertil Steril 1992;57:810-14
7. Filicori M, Flamigni C, Cognigni GE, et al. Different gonadotropin and leuprorelin ovulation induction regimens markedly affect follicular fluid hormone levels and folliculogenesis. Fertil Steril 1996;65:387-93
8. Dada T, Salha O, Baillie HS, Sharma V. A comparison of three gonadotrophin-releasing hormone analogues in an in-vitro fertilization programme: A prospective randomized study. Hum Reprod 1999;14:288-93
9. Geber S, Sales L, Sampaio MAC. Comparison between a single dose of goserelin (depot) and multiple daily doses of leuprolide acetate for pituitary suppression in IVF treatment: A clinical endocrinological study of the ovarian response. J Assist Reprod Genet 2002; 19:293-8
10. Dubourdieu S, Charbonnel B, Massai MR, et al. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: Effect of the dose and timing of human chorionic gonadotropin administration. Fertil Steril 1991; 56:440-5
11. Smitz J, Erard P, Devroey P, et al. Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRHagonists and HMG in a desensitization or flare-up protocol. Hum Reprod 1992;7:1225-9
12. Herman A, Ron-El R, Golan A, et al. Impaired corpus luteum function and other undesired results of pregnancies associated with inadvertent administration of a long-Acting agonist of gonadotrophin-releasing hormone. Hum Reprod 1992;7:465-8
13. Balasch J, Martinez F, Jové I, et al. Inadvertent gonadotrophinreleasing hormone agonist (GnRHa) administration in the luteal phase may improve fecundity in in-vitro fertilization patients. Hum Reprod 1993;8:1148-51
14. Cahill DJ, Fountain SA, Fox R, et al. Outcome of inadvertent administration of a gonadotrophin-releasing hormone agonist (buserelin) in early pregnancy. Hum Reprod 1994;9:1243-6
15. Platteau P, Gabbe M, Famelos M, et al. Should we still advise infertile couples to use (barrier) contraception before IVF downregulatioñ Fertil Steril 2000;74:655-9
16. Fujii S, Sato S, Fukui A, et al. Continuous administration of gonadotrophin-releasing hormone agonist during the luteal phase in IVF. Hum Reprod 2001;16:1671-5
17. Tesarik J, Hazout A, Mendoza-Tesarik R, et al. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist-And antagonist-Treated ovarian stimulation cycles. Hum Reprod 2006;21:2572-9
18. Isik AZ, Caglar GS, Sozen E, et al. Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: A prospective randomized study. Reprod Biomed Online 2009;19: 472-7
19. Isikoglu M, Ozgur K, Oehninger S. Extension of GnRH agonist through the luteal phase to improve the outcome of intracytoplasmic sperm injection. J Reprod Med 2007;52:639-44
20. Ata B, Yakin K, Balaban B, Urman B. GnRH agonist protocol administration in the luteal phase in ICSI-ET cycles stimulated with the long GnRH agonist protocol: A randomized, controlled double blind study. Hum Reprod 2008;23:668-73
21. Geber S, Sales L, Sampaio MA. Laboratory techniques for human embryos. Reprod Biomed Online 2002;5:211-18
22. Geber S, Sampaio M. Blastomere development after embryo biopsy: A new model to predict embryo development and to select for transfer. Hum Reprod 1999;14:782-6
23. Sampaio M, Geber S. Births after transfer of zona free blastocysts in oocyte donation cycles. J Assist Reprod Genet 2001;18: 156-9
24. Geber S, Moreira AC, de Paula SO, Sampaio M. Coparison between two forms of vaginally administered progesterone for luteal phase support in assisted reproduction cycles. Reprod Biomed Online 2007;14:155-8
25. Perry CM, Brogden RN. Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in benign gynaecological disorders. Drugs 1996;51:319-46
26. Albuquerque LE, Saconato H, Maciel MC. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles. Cochrane Database Syst Rev 2005;25:CD002808